Applying the semantic web to drug discovery and development
3 October 2005 , By Dr Eric Neumann , Fall 2005
Posted in Archive, Informatics | Tagged ADME / Tox, AI / data analytics / healthtech / informatics, Analysis, Analytical chemistry, Animal models, Assay development optimisation & technology, Automation / robotics, Biochemistry, Biomarkers, Business, Cellular assays, Chemical engineering, Chemistry, Clinical trials, Computational chemistry, Drug development, Drug discovery, Drug targets, Genetics / genomes, Genetics / genomics, Genomics, High Content Screening, High Throughput screening, Lead discovery, Metabolomics, Molecular medicine, Oncology, Pathology, Pharmacogenomics, Pharmacology, Pharmokinetics, Preclinical, Regulatory, RNA, Screening, System biology, Systems biology, Target validation, Toxicology Applying the semantic web to drug discovery and development By Dr Eric Neumann There is much happening in drug development these days: new target classes, increasing costs, new forms of high throughput screening, and the promise of personalised medicine. But of all the issues, the one that now takes centre stage (and directly impacts the [...]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!
